Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isopropyl alcohol + ketorolac is a **combination product** comprising isopropyl alcohol and ketorolac, intended in the provided context for the short-term management of moderately severe acute pain. The pharmacologically active analgesic component is **ketorolac**, a small-molecule nonsteroidal anti-inflammatory drug that produces analgesic effects primarily through nonselective inhibition of cyclooxygenase enzymes and consequent reduction in prostaglandin synthesis. Isopropyl alcohol does not contribute a recognized systemic analgesic mechanism in this context and is better interpreted as a formulation excipient or vehicle rather than an independently developed therapeutic active for pain control. Based on the supplied evidence, this entry appears to be a nonstandard naming of a ketorolac-containing formulation rather than a well-established distinct branded drug entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + ketorolac.